ALB · Categories · Downgrades
ALB - Analyst downgrades
Albemarle Corporation (ALB) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for ALB
- Albemarle downgraded by Rothschild & Co Redburn with a new price targetRothschild & Co Redburn downgraded Albemarle from Buy to Neutral and set a new price target of $188.00
- Albemarle downgraded by Robert W. Baird with a new price targetRobert W. Baird downgraded Albemarle from Outperform to Neutral and set a new price target of $210.00
- Albemarle downgraded by BofA Securities with a new price targetBofA Securities downgraded Albemarle from Buy to Neutral and set a new price target of $100.00
- Albemarle downgraded by KeyBanc Capital MarketsKeyBanc Capital Markets downgraded Albemarle from Overweight to Sector Weight
- Albemarle downgraded by Robert W. Baird with a new price targetRobert W. Baird downgraded Albemarle from Neutral to Underperform and set a new price target of $60.00
- Albemarle downgraded by UBS with a new price targetUBS downgraded Albemarle from Neutral to Sell and set a new price target of $57.00
- Albemarle downgraded by Evercore ISIEvercore ISI downgraded Albemarle from Outperform to In-line
- Albemarle downgraded by Robert W. Baird with a new price targetRobert W. Baird downgraded Albemarle from Outperform to Neutral and set a new price target of $85.00 from $102.00 previously
- Albemarle downgraded by Berenberg with a new price targetBerenberg downgraded Albemarle from Buy to Hold and set a new price target of $83.00 from $160.00 previously
- Albemarle downgraded by HSBC Securities with a new price targetHSBC Securities downgraded Albemarle from Buy to Hold and set a new price target of $95.00
- Albemarle downgraded by Wells Fargo with a new price targetWells Fargo downgraded Albemarle from Overweight to Equal Weight and set a new price target of $100.00 from $145.00 previously
- Albemarle downgraded by Scotiabank with a new price targetScotiabank downgraded Albemarle from Sector Outperform to Sector Perform and set a new price target of $135.00 from $150.00 previously
- Albemarle downgraded by Vertical Research with a new price targetVertical Research downgraded Albemarle from Buy to Hold and set a new price target of $145.00
- Albemarle downgraded by Citigroup with a new price targetCitigroup downgraded Albemarle from Buy to Neutral and set a new price target of $120.00 from $175.00 previously
- Albemarle downgraded by TD Cowen with a new price targetTD Cowen downgraded Albemarle from Outperform to Market Perform and set a new price target of $130.00 from $220.00 previously
- Albemarle downgraded by Deutsche Bank with a new price targetDeutsche Bank downgraded Albemarle from Buy to Hold and set a new price target of $135.00 from $155.00 previously
- Albemarle downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Albemarle from Neutral to Underweight and set a new price target of $128.00 from $140.00 previously
- Albemarle downgraded by UBS with a new price targetUBS downgraded Albemarle from Buy to Neutral and set a new price target of $140.00 from $253.00 previously
- Albemarle downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Albemarle from Overweight to Neutral and set a new price target of $155.00 from $255.00 previously
- Albemarle downgraded by BofA Securities with a new price targetBofA Securities downgraded Albemarle from Neutral to Underperform and set a new price target of $161.00 from $212.00 previously
- Albemarle downgraded by BofA Securities with a new price targetBofA Securities downgraded Albemarle from Neutral to Underperform and set a new price target of $195.00 from $262.00 previously
- Albemarle downgraded by Berenberg with a new price targetBerenberg downgraded Albemarle from Buy to Hold and set a new price target of $270.00 from $260.00 previously
- Albemarle downgraded by UBS with a new price targetUBS downgraded Albemarle from Buy to Neutral and set a new price target of $260.00 from $300.00 previously
- Albemarle downgraded by Goldman Sachs with a new price targetGoldman Sachs downgraded Albemarle from Neutral to Sell and set a new price target of $205.00